Dupilumab Suppresses Fractional Exhaled Nitric Oxide (FeNO) and Biomarkers of Type 2 Inflammation in Adult Patients with Persistent Uncontrolled Asthma Despite Use of Medium-to-High Dose Inhaled Corticosteroids Plus Long-Acting Beta-Agonists (ICS/LABAs)
Authors:
- Brian N. SwansonBSBrian N. Swanson
- Ariel TeperATAriel Teper
- Jennifer D. HamiltonJHJennifer D. Hamilton
- Bingzhi ZhangBZBingzhi Zhang
- Heribert StaudingerHSHeribert Staudinger
- Nian TianNTNian Tian
- Ying WangYWYing Wang
- Jeffrey E. MingJMJeffrey E. Ming
- Neil M.H. GrahamNGNeil M.H. Graham
- Gianluca PirozziGPGianluca Pirozzi
- 1 February 2016
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 137 (2) , AB190